Jane Street Group, LLC Dynavax Technologies Corp Put Options Transaction History

Jane Street Group, LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	SELL	$9.75 - $14.44 $1.47 Million - $2.18 Million	-150,900 Reduced 56.84%	114,600 $1.24 Million
Q4 2021 Feb 15, 2022	SELL	$13.17 - $20.94 $345,054 - $548,628	-26,200 Reduced 8.98%	265,500 $3.74 Million
Q3 2021 Nov 16, 2021	BUY	$9.16 - $19.83 $859,208 - $1.86 Million	93,800 Added 47.4%	291,700 $5.6 Million
Q2 2021 Aug 16, 2021	BUY	$7.25 - $10.99 $455,300 - $690,172	62,800 Added 46.48%	197,900 $1.95 Million
Q1 2021 May 18, 2021	BUY	$4.57 - $11.18 $338,180 - $827,320	74,000 Added 121.11%	135,100 $1.33 Million
Q4 2020 Feb 17, 2021	SELL	$3.73 - $5.6 $24,245 - $36,400	-6,500 Reduced 9.62%	61,100 $272,000
Q3 2020 Nov 17, 2020	BUY	$4.32 - $11.7 $103,680 - $280,800	24,000 Added 55.05%	67,600 $292,000
Q2 2020 Aug 17, 2020	BUY	$2.94 - $9.1 $95,550 - $295,750	32,500 Added 292.79%	43,600 $387,000
Q3 2017 Nov 14, 2017	BUY	$15.2 - $21.5 $168,720 - $238,650	11,100	11,100 $239,000

275

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.63B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.